Latest colitis Stories

Calendar Announcement/ Event Listing; Attention: Society/Event Editors Philadelphia, PA (PRWEB) March 28, 2012 The Philadelphia/Delaware Valley Chapter of the Crohn’s & Colitis Foundation of America will host its 37th annual Got Guts Gala on Saturday, April 21, 2012 at 7 p.m. This is the premier fund-raising event for the Chapter, benefiting Crohn’s disease and ulcerative colitis patients and their families. The Gala is an opportunity for the Chapter to recognize individuals for...

Researchers from the Hotchkiss Brain Institute (HBI) and the Snyder Institute for Chronic Diseases at the University of Calgary's Faculty of Medicine have discovered a pathway that may contribute to the symptoms related to Crohn's disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD). This research is a major milestone in developing future drug therapies for those living with these debilitating disorders. The digestive process is complex. To coordinate the...

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn’s disease, a form of inflammatory bowel disease (IBD).  CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties. In collaboration with the Division of Gastroenterology and Hepathology at University of North...

LEXINGTON, Mass., March 19, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease. Avaxia Biologics has been awarded a Phase II Small Business Innovation Research (SBIR) grant...

According to court documents, on February 27th, 2012 the New Jersey Supreme Court ruled that Kamie S. Kendall, the plaintiff in a $10.5 million lawsuit over Accutane, did not miss the state's two-year statute of limitations when she filed the suit in 2005 (A-73-2010 – 066802). Accutane (isotretinoin), a popular acne medication introduced in 1982, is manufactured by Hoffman-LaRoche, Inc. Kendall, who accuses Accutane for her ulcerative colitis, started taking Accutane for her acne in...

Many children with Crohn’s disease and ulcerative colitis who received treatment through ImproveCareNow, a national quality improvement and research network, ceased to have symptoms and no longer needed to take steroids for disease management. These are the findings from a study appearing in Pediatrics that examined the ImproveCareNow network’s quality improvement efforts and their impact on outcomes. In this study, the proportion of children with Crohn’s disease who were in remission...

FREIBURG and HEIDELBERG, Germany, March 8, 2012 /PRNewswire/ -- Dr. Falk Pharma GmbH to initiate Phase III trial Dr. Falk Pharma GmbH and Lipid Therapeutics, a biotechnology company focused on novel treatments for inflammatory bowel disease, today announced that they have entered into a licensing agreement for the European rights to Lipid Therapeutics' lead product, LT-02, for ulcerative colitis (UC). The terms of the license include an upfront fee, milestones and...

PITTSBURGH, Feb. 6, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has successfully completed the acquisition of two dermatological products from Valeant Pharmaceuticals. Mylan has acquired the abbreviated new drug application (ANDA) for Clindamycin Phosphate / Benzoyl Peroxide Gel, which is the generic version of Valeant's BenzaClin(®). Mylan previously had manufactured and marketed the generic version of this product through a licensing...

On February 4, 2012 at Parx Casino, the Philadelphia/Delaware Valley Chapter of the Crohn’s & Colitis Foundation of America (CCFA) will host its third Zumba Fundraiser for Crohn’s & colitis. Bensalem, PA (PRWEB) January 23, 2012 On February 4, 2012 at Parx Casino, the Philadelphia/Delaware Valley Chapter of the Crohn’s & Colitis Foundation of America (CCFA) will host its third Zumba Fundraiser for Crohn’s & colitis. All money raised at the event will benefit the...

The incidence and prevalence of inflammatory bowel disease (IBD) are increasing with time and in different regions around the world, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. "Insight into the worldwide epidemiology of inflammatory bowel disease is important for the identification of geographic patterns and time trends," said Gilaad G. Kaplan, MD, MPH, of the University of Calgary and lead author of this study. "Our...